{"id":"https://openalex.org/W55001683","doi":null,"title":"Pharmacologic approaches to reversing multidrug resistance.","display_name":"Pharmacologic approaches to reversing multidrug resistance.","publication_year":1997,"publication_date":"1997-10-01","ids":{"openalex":"https://openalex.org/W55001683","mag":"55001683","pmid":"https://pubmed.ncbi.nlm.nih.gov/9408960"},"language":"en","primary_location":{"id":"pmid:9408960","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9408960","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in hematology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019649110","display_name":"Branimir Ivan Sikic","orcid":"https://orcid.org/0000-0001-6814-2070","observed_orcids":["https://orcid.org/0000-0001-6814-2070"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"B I Sikic","raw_affiliation_strings":["General Clinical Research Center, Stanford University, CA 94305, USA. mv.bis@forsythe.stanford.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Clinical Research Center, Stanford University, CA 94305, USA. mv.bis@forsythe.stanford.edu","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5019649110"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":5.9709,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.96719728,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"34","issue":"4 Suppl 5","first_page":"40","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9929999709129333},{"id":"https://openalex.org/keywords/psc-833","display_name":"PSC833","score":0.9430000185966492},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibitors","display_name":"P-glycoprotein inhibitors","score":0.699999988079071},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.5809999704360962},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5720000267028809},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/drug-disposition","display_name":"drug disposition","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.8416522145271301},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.7691500186920166},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6645143628120422},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5578356385231018},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5269737243652344},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5249897241592407},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4878408908843994},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47205930948257446},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4171842932701111},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.41599804162979126},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3345109224319458},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2931913733482361},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.28093862533569336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25335896015167236},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9408960","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9408960","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in hematology","raw_type":"Journal Article"},{"id":"mag:55001683","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9408960","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1988234658","https://openalex.org/W201382108","https://openalex.org/W2277869106","https://openalex.org/W1971175458","https://openalex.org/W149606796","https://openalex.org/W7070502811","https://openalex.org/W2126371858","https://openalex.org/W84182309","https://openalex.org/W162196038","https://openalex.org/W2119707395"],"abstract_inverted_index":{"The":[0,140,160,306],"rationale":[1],"for":[2],"modulation":[3,101,312],"of":[4,10,32,49,72,79,93,100,102,116,128,131,154,166,171,176,200,232,290,301,310],"multidrug":[5,12],"resistance":[6,122,132,172],"(MDR)":[7],"by":[8,23,60,91,107,147],"inhibitors":[9,153],"the":[11,17,77,117,126,174,201,212,239,263],"transporter,":[13],"P-glycoprotein":[14],"(P-gp)":[15],"includes":[16],"following:":[18],"(1)":[19],"P-gp":[20,35,55,83,155,233,244,260,266,291],"is":[21,186,245,267,316],"expressed":[22],"human":[24],"cancers,":[25],"either":[26],"at":[27,37,225,297],"diagnosis":[28,38],"or":[29,180],"after":[30],"failure":[31],"chemotherapy;":[33],"(2)":[34],"expression":[36,56,84],"has":[39],"been":[40,105],"associated":[41,187],"with":[42,188,192,283,313],"a":[43,205,216,249],"poor":[44],"prognosis":[45],"in":[46,63,67,88,123,133,136,227,234,251,271,295,320,325],"some":[47],"types":[48],"cancer;":[50],"(3)":[51],"MDR":[52,80,103,311],"related":[53,81],"to":[54,82,112,119,138,178,203,211,230,247],"can":[57,85,292],"be":[58,86,145,293],"reversed":[59],"modulators,":[61],"resulting":[62],"enhanced":[64],"therapeutic":[65,308],"efficacy":[66],"cellular":[68,89,169],"and":[69,75,96,125,151,173,208,223,241,280,304,330],"animal":[70],"models":[71,90],"drug":[73,121,190,219,252,273],"resistance;":[74],"(4)":[76],"emergence":[78],"prevented":[87],"co-administration":[92],"MDR-related":[94,193,272],"cytotoxins":[95,202],"modulators.":[97],"Clinical":[98],"trials":[99,282,324],"have":[104],"limited":[106],"two":[108],"major":[109],"factors:":[110],"inability":[111],"achieve":[113,204],"adequate":[114],"levels":[115],"modulators":[118],"reverse":[120],"patients":[124,296],"presence":[127],"other":[129],"mechanisms":[130,170],"tumor":[134],"cells":[135],"addition":[137],"P-gp.":[139],"former":[141],"limitation":[142],"will":[143,162],"hopefully":[144],"overcome":[146,179],"new,":[148],"more":[149],"potent":[150],"specific":[152],"such":[156,237],"as":[157,238],"PSC":[158,184,284,314],"833.":[159],"latter":[161],"require":[163,197],"further":[164],"understanding":[165],"various":[167],"alternative":[168],"development":[175],"approaches":[177],"circumvent":[181],"these":[182],"mechanisms.":[183],"833":[185,285,315],"significant":[189],"interactions":[191,220],"cytotoxic":[194],"agents,":[195],"which":[196,258],"dose":[198,206],"reduction":[199],"exposure":[207],"toxicity":[209],"similar":[210],"chemotherapy":[213],"agents":[214],"without":[215],"modulator.":[217],"These":[218],"are":[221,224],"predictable":[222],"least":[226],"part":[228],"due":[229],"inhibition":[231,289],"normal":[235],"tissues":[236],"liver":[240],"kidneys,":[242],"where":[243],"known":[246],"play":[248],"role":[250],"excretion.":[253],"Data":[254],"from":[255,277],"knockout":[256],"mice,":[257],"lack":[259],"expression,":[261],"support":[262],"concept":[264],"that":[265,287],"an":[268],"important":[269],"factor":[270],"disposition.":[274],"Early":[275],"data":[276],"phase":[278,321],"I":[279],"II":[281],"indicate":[286],"substantial":[288],"achieved":[294],"clinically":[298],"tolerable":[299],"doses":[300],"both":[302],"modulator":[303],"cytotoxins.":[305],"ultimate":[307],"benefit":[309],"currently":[317],"being":[318],"tested":[319],"III":[322],"clinical":[323],"acute":[326],"myeloid":[327],"leukemias":[328],"(AMLs)":[329],"multiple":[331],"myeloma.":[332]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}